» Articles » PMID: 36245062

Cohort Profile: the Food Chain Plus (FoCus) Cohort

Abstract

The Food Chain Plus (FoCus) cohort was launched in 2011 for population-based research related to metabolic inflammation. To characterize this novel pathology in a comprehensive manner, data collection included multiple omics layers such as phenomics, microbiomics, metabolomics, genomics, and metagenomics as well as nutrition profiling, taste perception phenotyping and social network analysis. The cohort was set-up to represent a Northern German population of the Kiel region. Two-step recruitment included the randomised enrolment of participants via residents' registration offices and via the Obesity Outpatient Centre of the University Medical Center Schleswig-Holstein (UKSH). Hence, both a population- and metabolic inflammation- based cohort was created. In total, 1795 individuals were analysed at baseline. Baseline data collection took place between 2011 and 2014, including 63% females and 37% males with an age range of 18-83 years. The median age of all participants was 52.0 years [IQR: 42.5; 63.0 years] and the median baseline BMI in the study population was 27.7 kg/m [IQR: 23.7; 35.9 kg/m]. In the baseline cohort, 14.1% of participants had type 2 diabetes mellitus, which was more prevalent in the subjects of the metabolic inflammation group (MIG; 31.8%). Follow-up for the assessment of disease progression, as well as the onset of new diseases with changes in subject's phenotype, diet or lifestyle factors is planned every 5 years. The first follow-up period was finished in 2020 and included 820 subjects.

Citing Articles

Prediabetes and type 2 diabetes but not obesity are associated with alterations in bile acid related gut microbe-microbe and gut microbe-host community metabolism.

Schlicht K, Pape L, Rohmann N, Knappe C, Epe J, Geisler C Gut Microbes. 2025; 17(1):2474143.

PMID: 40045464 PMC: 11901388. DOI: 10.1080/19490976.2025.2474143.


Comprehensive evaluation of diabetes subtypes in a European cohort reveals stronger differences of lifestyle, education and psychosocial parameters compared to metabolic or inflammatory factors.

Rohmann N, Epe J, Geisler C, Schlicht K, Turk K, Hartmann K Cardiovasc Diabetol. 2025; 24(1):99.

PMID: 40022072 PMC: 11871841. DOI: 10.1186/s12933-025-02660-5.


Metabolic and lifestyle factors accelerate disease onset and alter gut microbiome in inflammatory non-communicable diseases.

Rohmann N, Geese T, Nestel S, Schlicht K, Geisler C, Turk K BMC Med. 2024; 22(1):493.

PMID: 39449123 PMC: 11515311. DOI: 10.1186/s12916-024-03709-0.


Effects of lifestyle and associated diseases on serum CC16 suggest complex interactions among metabolism, heart and lungs.

Rohmann N, Sturmer P, Geisler C, Schlicht K, Knappe C, Hartmann K J Adv Res. 2023; 59:161-171.

PMID: 37330047 PMC: 11081936. DOI: 10.1016/j.jare.2023.06.005.

References
1.
Reitmeier S, Kiessling S, Clavel T, List M, Almeida E, Ghosh T . Arrhythmic Gut Microbiome Signatures Predict Risk of Type 2 Diabetes. Cell Host Microbe. 2020; 28(2):258-272.e6. DOI: 10.1016/j.chom.2020.06.004. View

2.
Schulz M, Hoffmann K, Weikert C, Nothlings U, Schulze M, Boeing H . Identification of a dietary pattern characterized by high-fat food choices associated with increased risk of breast cancer: the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Br J Nutr. 2008; 100(5):942-6. DOI: 10.1017/S0007114508966149. View

3.
Anderson C, Pettersson F, Clarke G, Cardon L, Morris A, Zondervan K . Data quality control in genetic case-control association studies. Nat Protoc. 2010; 5(9):1564-73. PMC: 3025522. DOI: 10.1038/nprot.2010.116. View

4.
Wishart D, Tzur D, Knox C, Eisner R, Guo A, Young N . HMDB: the Human Metabolome Database. Nucleic Acids Res. 2007; 35(Database issue):D521-6. PMC: 1899095. DOI: 10.1093/nar/gkl923. View

5.
Ridker P, Everett B, Thuren T, MacFadyen J, Chang W, Ballantyne C . Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease. N Engl J Med. 2017; 377(12):1119-1131. DOI: 10.1056/NEJMoa1707914. View